mHealth Service Linkage for Young Adults Impacted by the Criminal Legal System (LYNX)
2026年5月13日 更新者：Emily Dauria、University of Pittsburgh
Technology Enhanced Substance Use and HIV Service Navigation for Justice-Involved Young Adults
This study is designed to test Project LYNX, a program designed to help young adults (ages 18-29) with recent criminal legal system involvement can find and get connected to substance use and HIV-prevention services in the community. The program combines support from a trained peer navigator with easy-to-use digital tools.
The study will:
- Adapt an existing navigator program by adding new digital (eHealth) tools that were co-developed with young adults. These tools will help navigators refer participants to the right health services.
- Refine and test the updated program to make sure it works well and is easy to use.
- Evaluate whether the program is feasible, acceptable, and helpful in linking young adults to substance use treatment and HIV-prevention services.
The overall goal is to create a practical, user-friendly system that supports young adults find and get connected to services for substance use and HIV prevention that they need.
調査の概要
研究の種類
介入
入学 (推定)
50
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究連絡先
- 名前：Emily Dauria, PhD, MPH
- 電話番号：412-383-0732
- メール：efd16@pitt.edu
研究連絡先のバックアップ
- 名前：Sheridan Sweet, MPH
- 電話番号：(412) 613-8817
- メール：SHS406@pitt.edu
研究場所
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15206
- University of Pittsburgh, School of Public Health
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
はい
説明
Inclusion Criteria:
- Self-report recent criminal legal involvement (past year);
- Self-identify as HIV-negative
- Endorse behaviors in the past 6 months indicating consideration of PrEP per the Center for Disease Control and Prevention's (CDC) risk indices
- Meet the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tools' criteria for identifying the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) substance use disorder
- Are conversant in English.
Exclusion Criteria:
- Being on PrEP
- Cognitive delays that would interfere with consent or participation
- Inability to provide contact information for >2 locator individuals
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Standard of Care
Standard of care will involve young adults (18 to 29 years) impacted by the criminal legal system engaging in and connecting with HIV and substance use services in healthcare systems via warm referral to services in the community.
|
Standard of care will involve young adults (18 to 29 years) impacted by the criminal legal system engaging in and connecting with HIV and substance use services in healthcare systems via warm referral to services in the community.
|
|
実験的：LYNX Intervention
Project LYNX is a new program designed to help young adults involved in the criminal legal system (ages 18-29) get connected to substance use treatment and HIV-prevention services.
|
LYNX is an mHealth enhanced, adapted navigator program designed to refer and link young adults (18 to 29 years) impacted by the criminal legal system to services related to substance use and HIV.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Linkage to substance use services
時間枠：Time Frame: 4 month post-enrollment
|
Substance use service linkage will be attendance at a substance use service appointment via self-report via the question: " Did you attend your first appointment with your substance use treatment provider?"
Yes or No.
We will report the number of participants that answered with each response option.
|
Time Frame: 4 month post-enrollment
|
|
Linkage to PrEP Services
時間枠：Time Frame: 4 month post-enrollment
|
Pre-exposure Prophylaxis linkage will be self-reported engagement in PrEP related services in the last month via the question " Have you received any PrEP-related services in the past [month/3 months]?" Yes or No.
We will report the number of participants that answered with each response option.
|
Time Frame: 4 month post-enrollment
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
PrEP Referral
時間枠：Time Frame: 4 month post-enrollment
|
PrEP referral be reported via self-report via the question: "Has your navigator offered to connect you to PrEP services?"
Yes or No.
We will report the number of participants that answered with each response option.
|
Time Frame: 4 month post-enrollment
|
|
Time to PrEP Linkage
時間枠：Time Frame: 4 month post-enrollment
|
Time to linkage will be reported by the LYNX navigator based on the date they referred the participant to PrEP services and the date they recorded the participant first attended a PrEP related appointment.
We will report the average number of days between the date of referral and first appointment attendance.
|
Time Frame: 4 month post-enrollment
|
|
Receipt of PrEP Prescription
時間枠：Time Frame: 4 month post-enrollment
|
Receipt of a PrEP prescription will be identified via self-report via the question "Have you received a prescription for PrEP?".
Yes or No.
We will report the number of participants that answered with each response option.
|
Time Frame: 4 month post-enrollment
|
|
Fill of PrEP Prescription
時間枠：Time Frame: 4 month post-enrollment
|
Fill of a PrEP prescription will be identified via self-report via the question: "Have you filled your PrEP prescription?"
Yes or No.
We will report the number of participants that answered with each response option.
|
Time Frame: 4 month post-enrollment
|
|
PrEP Initiation
時間枠：Time Frame: 4 month post-enrollment
|
PrEP initiation will be identified via self-report via the question: "Have you started to take PrEP?" Yes or No .
We will report the number of participants that answered with each response option.
|
Time Frame: 4 month post-enrollment
|
|
PrEP Adherence
時間枠：Time Frame: 4-month post-enrollment
|
PrEP adherence will be identified via self-report via the question: "In the past 30 days, rate your ability to take your PrEP medications as prescribed?"
Very often, Somewhat often, Often, Not very often, Never.
We will report the number of participants that answered with each response option.
|
Time Frame: 4-month post-enrollment
|
|
PrEP Persistence
時間枠：Time Frame: 4-month post-enrollment
|
PrEP persistence will be identified through self-report via the question: "Have you stopped taking PrEP?: Yes or No.
We will report the number of participants that answered with each response option.
|
Time Frame: 4-month post-enrollment
|
|
Accepted Substance Use Service Referral
時間枠：Time Frame: 4 month post-enrollment
|
Accepted substance use treatment referral will be reported via self-report via the question: "Has your navigator offered to connect you to substance use services?"
Yes or No.
We will report the number of participants that answered with each response option.
|
Time Frame: 4 month post-enrollment
|
|
Time to Substance Use Linkage
時間枠：Time Frame: 4 month post-enrollment
|
Time to linkage will be reported by the LYNX navigator based on the date they referred the participant to substance use services and the date they recorded the participant first attended a substance use related appointment.
We will report the average number of days between the date of referral and first appointment attendance.
|
Time Frame: 4 month post-enrollment
|
|
Navigation Satisfaction Tool
時間枠：Time Frame: 4-month post-enrollment
|
The Navigation Satisfaction Tool (NAVSAT) includes twelve items that address client satisfaction with navigation services (e.g., How satisfied are you with the navigator's ability to listen and understand your concerns?
How satisfied are you with the frequency of contact with the navigator?).
Items are rated on a Likert scale from 1 (extremely dissatisfied / extremely unhelpful) to 7 (satisfied/ extremely satisfied).
A total item score is calculated.
Higher scores reflect greater navigator satisfaction.
We will report the mean and the standard deviation for the NAVSAT score.
|
Time Frame: 4-month post-enrollment
|
|
Client Intervention Satisfaction
時間枠：Baseline, 1-month post enrollment, 3-months post-enrollment
|
The Study Participant Feedback Questionnaire (SPFQ) comprises 23-questions and is split into three brief, validated questionnaires capturing trial experience at baseline, mid-point, and end of the study.
The majority of items use a 5-point Likert satisfaction response scale.
Some questions use a yes/no scale.
The SPFQ is not designed to produce a single composite score.
Responses will be analyzed item by item and reported as frequency distributions for each individual question, by response.
|
Baseline, 1-month post enrollment, 3-months post-enrollment
|
|
Perceived Navigator Similarity
時間枠：Time Frame: 4-month post-enrollment
|
The Perceived Navigator Similarity scale consists of 10 items - 5 related to personal similarity and 5 related to ethnic similarity.
Patients respond to each item using a 6-point Likert scale ranging from 0 (very different) to 5 (very similar).
We will calculate a total score by summing all items, with higher scores indicating greater perceived similarity.
|
Time Frame: 4-month post-enrollment
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
捜査官
- 主任研究者：Emily Dauria, PhD, MPH、University of Pittsburgh
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
便利なリンク
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (推定)
2026年7月1日
一次修了 (推定)
2026年8月30日
研究の完了 (推定)
2027年2月1日
試験登録日
最初に提出
2026年5月13日
QC基準を満たした最初の提出物
2026年5月13日
最初の投稿 (実際)
2026年5月20日
学習記録の更新
投稿された最後の更新 (実際)
2026年5月20日
QC基準を満たした最後の更新が送信されました
2026年5月13日
最終確認日
2026年5月1日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- STUDY22020053 (Aim 3)
- 5R34DA057891-03 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
IPD プランの説明
No individual participant data will be shared.
Results will be published by the investigators in academic journals.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。